1800-272-662
Shopping Cart 0
countryflagAU
Login

Painchek Ltd

Healthcare AU PCK

0.165AUD
-0.01(5.71%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.170.17
LowHigh

52 Week Range

0.171.05
LowHigh

Fundamentals

  • Previous Close 0.17
  • Market Cap35.53M
  • Volume58597
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.20161M
  • Revenue TTM3.44M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 0.97M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -7.67223M -8.30796M -7.57473M -5.72053M -6.06365M
Minority interest - - - - -
Net income -7.67223M -8.30796M -7.57473M -5.72053M -6.06365M
Selling general administrative 3.22M 3.40M 3.87M 3.05M 3.80M
Selling and marketing expenses 2.64M 2.05M 1.86M 1.66M 1.57M
Gross profit 1.00M 0.73M 0.71M -0.25883M -0.42421M
Reconciled depreciation - 0.03M 0.02M 0.01M 0.06M
Ebit -7.67223M -9.51407M -8.77916M -7.60384M -9.02859M
Ebitda -7.65407M -9.48850M -8.76218M -7.58941M -8.96934M
Depreciation and amortization 0.02M 0.03M 0.02M 0.01M 0.06M
Non operating income net other - - - - -
Operating income -9.11184M -9.51407M -7.58454M -5.73034M -6.14193M
Other operating expenses 12.47M 12.19M 9.53M 6.71M 6.30M
Interest expense - - - 0.02M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - 0.00675M 0.00635M 0.02M 0.02M
Net interest income - 0.00675M 0.00635M 0.02M 0.02M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -1.20611M -0.02333M -0.03001M -0.07835M
Total revenue 3.36M 2.67M 1.95M 0.98M 0.21M
Total operating expenses 10.11M 10.24M 9.49M 7.35M 8.60M
Cost of revenue 2.36M 1.95M 1.24M 1.24M 0.64M
Total other income expense net 1.44M 1.21M 1.18M 1.85M 2.89M
Discontinued operations - - - - -
Net income from continuing ops - -8.30796M -7.57473M -5.72053M -6.06365M
Net income applicable to common shares -7.67223M -8.30796M -7.57473M -5.72053M -6.06365M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 2.15M 4.18M 2.80M 6.65M 11.81M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.07M 0.07M - -0.00000M -0.00000M
Total liab 3.26M 2.89M 2.13M 1.83M 3.57M
Total stockholder equity -1.11293M 1.29M 0.67M 4.82M 8.24M
Deferred long term liab - - - - -
Other current liab 2.46M 1.14M 1.63M 1.55M 3.24M
Common stock 47.60M 43.39M 35.18M 32.48M 30.74M
Capital stock - - 35.18M 32.48M 30.74M
Retained earnings -64.56028M -56.88806M -48.58010M -41.00537M -35.28484M
Other liab - - - - 0.00000M
Good will - - - - -
Other assets - - - - -
Cash 1.62M 3.56M 2.51M 6.14M 11.42M
Cash and equivalents - - 2.51M 6.14M 11.42M
Total current liabilities 3.26M 2.89M 2.13M 1.83M 3.57M
Current deferred revenue - 0.91M - - -
Net debt -1.61722M -3.56159M -2.51222M -6.14142M -11.41951M
Short term debt - - 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - 14.07M 13.34M 12.79M
Property plant equipment - - 0.02M 0.03M 0.02M
Total current assets 2.13M 4.15M 2.77M 6.63M 11.79M
Long term investments - - - - -
Net tangible assets - - 0.67M 4.82M 8.24M
Short term investments - - - - -
Net receivables 0.45M 0.52M 0.20M 0.44M 0.32M
Long term debt - - - - -
Inventory - 0.00000M - 0.05M 0.06M
Accounts payable 0.80M 0.84M 0.50M 0.28M 0.33M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 15.84M 14.79M 14.07M 13.34M 12.79M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -0.02283M - -0.00018M
Deferred long term asset charges - - - - -
Non current assets total 0.02M 0.03M 0.02M 0.03M 0.02M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.03425M -0.01244M -0.02196M -0.06003M
Change to liabilities - - 0.18M -1.74899M 1.40M
Total cashflows from investing activities -0.01217M -0.03425M -0.01244M -0.02196M -0.06003M
Net borrowings - - - - -
Total cash from financing activities 4.82M 8.21M 2.70M 1.75M 9.48M
Change to operating activities - - 0.06M 0.03M 0.00304M
Net income -7.67223M -8.30796M -7.57473M -5.72053M -6.06365M
Change in cash -1.94437M 1.05M -3.62920M -5.27809M 5.30M
Begin period cash flow 3.56M 2.51M 6.14M 11.42M 6.12M
End period cash flow 1.62M 3.56M 2.51M 6.14M 11.42M
Total cash from operating activities -6.75351M -7.12756M -6.32272M -6.99750M -4.12105M
Issuance of capital stock - 8.67M 2.82M 1.94M 10.00M
Depreciation 0.02M 0.03M 0.02M 0.01M 0.06M
Other cashflows from investing activities - - 0.00120M - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.03M -0.22331M 0.24M -0.12093M -0.23262M
Sale purchase of stock 5.12M -0.45992M -0.12659M -0.19800M -0.52278M
Other cashflows from financing activities -0.30699M -0.03425M -0.01244M -0.02196M -0.06003M
Change to netincome - - 0.77M 0.55M 0.71M
Capital expenditures 0.01M 0.03M 0.01M 0.02M 0.06M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.11M 0.44M 0.24M -0.12093M -0.23262M
Stock based compensation 0.47M 0.71M 0.77M 0.55M 0.71M
Other non cash items 0.32M 0.44M 1.24M -1.29139M 1.88M
Free cash flow -6.76569M -7.16181M -6.33636M -7.01946M -4.18108M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PCK
Painchek Ltd		 -0.01 5.71% 0.17 - - 10.34 14.68 9.17 -3.653
PME
Pro Medicus Ltd		 -0.55 0.41% 133.00 59.62 73.53 58.00 36.74 58.50 75.61
AYA
ARTRYA Ltd		 -0.17 5.04% 3.20 - - 17488.26 5.98 5516.69 0.33
EIQ
Echoiq Ltd		 0.02 2.94% 0.70 - - 5046.68 25.81 4779.15 -8.2701
CGS
Cogstate Ltd		 -0.02 0.92% 2.15 23.89 19.96 6.58 5.14 4.32 13.45

Reports Covered

Stock Research & News

View All

Profile

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

Painchek Ltd

35 Lime Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Philip Daffas B.Sc., M.B.A., BSc, Dip EENG, MBA, GAICD MD, CEO & Director NA
Mr. Iain McAdam Chief Financial Officer NA
Mr. Andrew Hoggan Mang. & Head of Operations NA
Mr. Scott Robertson M.B.A. Chief Technology Officer NA
Prof. Jeff Hughes Ph.D. Chief Scientific Officer NA
Mr. David Allsopp Head of Bus. Devel. ANZ NA
Mr. Pete Shergill Head of Bus. Devel. UK NA
Ms. Sally McDow Company Sec. NA
Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. MD, CEO & Director NA
Mr. Andrew Hoggan Manager & Head of Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.